Sonoma Pharmaceuticals entered a non-exclusive Manufacturing and Supply Agreement with Kenvue Brands LLC to supply Microcyn-based products in the U.S. from October 2025 through March 2027.
Key takeaways
Agreement effective October 24, 2025, continuing through March 2027 with potential two one-year extensions.
Kenvue Brands LLC designated as Buyer; Sonoma Pharmaceuticals designated as Manufacturer.
Scope covers sale of Microcyn technology-based products in the United States and its territories.
Agreement is non-exclusive; Buyer has no minimum purchase obligations.
Pricing structure includes Conversion Price, Raw Materials Price, Waste Cost, and Transportation Cost.